Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Explore more Johnson & Johnson sites:
Switzerland
Page logo
Latest News

Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference
Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference

New Brunswick, NJ (February 9th, 2022) - Johnson & Johnson (NYSE: JNJ) will participate in the Raymond James 43rd Annual Institutional Investors Conference on Tuesday, March 8th. Joseph J. Wolk, Executive Vice President and Chief Financial Officer, will represent the Company in a session scheduled at 1:05 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

  • Media Contact
    Lindsay Hyman
    (732) 524-6297

    Investor Contact
    Lisa Romanko
    (732)524-2034
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue